ArticleOPEN ACCESS

What place will tezepelumab hold in the treatment paradigm in chronic rhinosinusitis?

Expert Review of Clinical Immunology
DOI: 10.1080/1744666X.2023.2215986
3Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Author supplied keywords

Cite

CITATION STYLE

APA

Favier, V., Charriot, J., Crampette, L., Bourdin, A., & Ahmed, E. (2023). What place will tezepelumab hold in the treatment paradigm in chronic rhinosinusitis? Expert Review of Clinical Immunology. Taylor and Francis Ltd. https://doi.org/10.1080/1744666X.2023.2215986

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free